Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stopping when the experimental regimen does not appear to help

S Wieand1, G Schroeder, J R O'Fallon

  • 1Cancer Center Statistics, Mayo Clinic, Rochester, MN 55905.

Statistics in Medicine
|July 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gamma knife radiosurgery for high grade glial neoplasms: a Canadian experience.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2013
Same author

Gamma knife in the treatment of pituitary adenomas: results of a single center.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2013
Same author

Gamma knife radiosurgery for large vestibular schwannomas: a Canadian experience.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2013
Same author

Extended adjuvant temozolomide with cis-retinoic acid for adult glioblastoma.

Current oncology (Toronto, Ont.)·2013
Same author

Gamma Knife radiosurgery of cavernous sinus meningiomas: an institutional review.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2012
Same author

Blastomycosis presenting as multiple splenic masses.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012

This study introduces a procedure to reduce patient enrollment in ineffective cancer cancer clinical trial regimens. It offers a 50% chance of stopping accrual to therapies without added benefit, minimizing power loss.

Area of Science:

  • Clinical trials methodology
  • Biostatistics
  • Oncology research

Background:

  • Advanced cancer trials often have long accrual periods exceeding median survival.
  • Ineffective experimental regimens expose patients to unnecessary risks and resource waste.

Purpose of the Study:

  • To present a statistical procedure for early termination of ineffective cancer clinical trial arms.
  • To evaluate the efficiency and statistical properties of this early stopping procedure.

Main Methods:

  • The proposed procedure allows for stopping patient accrual to experimental arms if they prove no more effective than the standard regimen.
  • Analysis focuses on the probability of early termination and the associated loss of statistical power.

Main Results:

Related Experiment Videos

  • The procedure provides a 50% probability of stopping accrual to ineffective therapies.
  • The associated loss of statistical power is minimal, reported as less than 0.02.

Conclusions:

  • This method is particularly valuable for advanced cancer trials where accrual time is lengthy.
  • It offers a practical and statistically sound approach to optimize resource allocation and patient safety in clinical research.